Monoclonal antibodies are becoming a leading class of biopharmaceuticals but to increase their accessibility to the general population, new production processes must be developed in particular for the downstream processing. In this publication, researchers from BERG-iBB (Ana Azevedo and Raquel Aires-Barros) in collaboration with the biotechnology companies Biomedal S.L. (Seville, Spain) and ChiPro GmbH (Bremen, Germany) propose an alternative and innovative affinity chromatographic purification method using quaternary amine anion-exchange matrices. Separation is driven by the dual affinity ligand LYTAG-Z, composed of a choline binding polypeptide (LYTAG) and the synthetic antibody binding Z domain. Click on title to learn more.